IDEXX Laboratories Stock News

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Welcome to part two of this three-part series. In part one, we looked at the importance of timing and identifying high-probability assets across all markets. In part two, we look at why being a good s

Sector ETF report for PTH

A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.

That prediction might be too conservative.

That prediction might be too conservative.

IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.

IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.

U.S. indices fell Monday in anticipation of expected Fed rate hikes this year as the Fed seeks to curb inflation. A rise in bond yields has pressured technology and growth stock valuations. The 10-yea

Latest data indicates that Accuray's (ARAY) CyberKnife System is effective in providing long-lasting pain relief to patients suffering from TN.

Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.

Masimo's (MASI) first-quarter 2022 results are likely to have been dampened by supply chain headwinds.

LHC Group's (LHCG) deal with Optum is likely to enhance and extend value-based care to patients' homes.

Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.

Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business.